ASHPOfficial

In this episode, our presenters at the 2022 Midyear Clinical Meeting review the signs and symptoms of Monkey Pox along with the current pharmacological options for treatment.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, anesthesia and pharmacy leaders explore the potential impact of implementing radio frequency identification technology on patient and medication safety in care settings where sedation is administered. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will review key concepts of pain management in patients with cancer, as well as key findings on drug interactions between various pain medications and immunotherapy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will explore the recent advancements in community pharmacy practice in the northwest and their implementation into practice.   Discussions will include independent prescribing, test-treat protocols, preventative health services, disease state management, and the medical billing necessary to sustain these services.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Major Depressive Disorder (MDD) is common psychiatric condition that causes significant disability and disease burden.  Treatment for this condition may require multiple medication trials.  Up to thirty percent of individuals with MDD do not receive adequate benefit from several antidepressant drug trials and are considered treatment resistant.  The management of treatment resistant depression (TRD) often requires novel approaches.  One such approach is to use N-methyl-D-aspartate (NMDA) receptor antagonists such as ketamine or esketamine.  This session will review the use of ketamine and esketamine for TRD.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of alopecia areata.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the 2022 Midyear Clinical Meeting, our content matter experts share updates to the NIOSH guidance and practical implications surrounding USP 800.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. In this second podcast on nanomedicines, pharmacists will be provided with examples of nanomedicines, their challenges, formulary considerations, and future.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.